Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Anemia is the defining feature in most patients with myelodysplastic syndromes (MDS), yet defects in erythropoiesis have not been well characterized. We examined freshly obtained bone marrow (BM) samples for stage-specific abnormalities during terminal erythroid differentiation (TED) from 221 sample...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Ali, Abdullah Mahmood, Huang, Yumin, Pinheiro, Ronald Feitosa, Xue, Fumin, Hu, Jingping, Iverson, Nicholas, Hoehn, Daniela, Coutinho, Diego, Kayani, Jehanzeb, Chernak, Brian, Lane, Joseph, Hillyer, Christopher, Galili, Naomi, Jurcic, Joseph, Mohandas, Narla, An, Xiuli, Raza, Azra
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2018
Konular:
Myeloid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020814/
https://ncbi.nlm.nih.gov/pubmed/29903708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018018440
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller